CLINICAL_TRIALS
trial_result
· 2022-04-20
Clinical Trial Update: Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants [Phase 3]
Summary
Phase 3 trial of Pneumosil given in a 2+1 schedule to healthy infants; completed with posted results in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PATH | Conditions: Pneumonia, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2022-04-20